BioHealth News Archive
Vtesse Advances Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease with Dose Selection for Evaluation in Second and Final Portion of Trial and Expansion into Europe
Vtesse, Inc. announced today that the dose-finding portion of the company’s global, pivotal Phase 2b/3 clinical trial for its lead investigational product, VTS-270, for treatment…
Read More
OrbiMed launches second fund targeting Israeli biotech, health tech investments – MedCity News
OrbiMed has launched a $307 million venture capital fund five years after its inagural $202 million fund investing in biotech, diagnostic and medical device…
Read More
IBM Launches Cognitive Cybersecurity Lab In Baltimore – CivSource
IBM is partnering with the University of Maryland, Baltimore County (UMBC) to create the Accelerated Cognitive Cybersecurity Laboratory (ACCL), which will be housed within…
Read More
The Washington region is poised to dominate the new biodata industry – Washington Business Journal
The Washington region is poised to dominate a new billions-dollar industry. {iframe}http://www.bizjournals.com/washington/print-edition/2016/05/20/the-biodata-gold-rush.html{/iframe}
Read More
Avalon, GSK form 8th San Diego biotech – SanDiegoUnionTribune.com
Extending their partnership to an eighth company, La Jolla's Avalon Ventures and UK-based drug giant GSK said Friday they have formed another San Diego…
Read More
STEM education can help boost Baltimore’s economy, Johns Hopkins president says – Hub
Johns Hopkins University President Ronald J. Daniels was among the speakers Thursday at the fifth annual U.S. News & World Report STEM Solutions National…
Read More
Roche VC fund drives genomics sample prep player to $18.2M Series A – FierceBiotech
Roche Venture Fund and 5AM Ventures have led Purigen Biosystems to an $18.2 million Series A round. Purigen will use the money to advance…
Read More
Here’s who won this year’s TEDCO ICE Awards – Technical.ly Baltimore
TEDCO handed out its annual honors for “Innovation,” “Corporate Excellence” and “Entrepreneurship” on Tuesday. The ICE Awards ceremony at Columbus Center in Inner Harbor…
Read More
QIAGEN Extends Tender Offer Period for Acquisition of Exiqon A/S
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the extension of the offer period for the acquisition of Exiqon A/S, a world…
Read More
Roche Gets Accelerated Approval for Immunotherapy Drug – Zacks.com
Roche Holding (RHHBY - Analyst Report) announced that the FDA has granted accelerated approval to its cancer immunotherapy drug, Tecentriq (atezolizumab), for the treatment…
Read More
People who live the longest share these personality traits – Business Insider
Decades of research have linked specific personality traits to a longer life expectancy. Some of them — from friendliness to emotional stability — may…
Read More
2016 Global Board Survey Report – WomenCorporateDirectors
What 4000+ corporate directors think about the economy, risk, board strengths and weaknesses, and boardroom diversity “Boards cannot afford to have directors around the…
Read More
Kevin Plank urges University of Maryland graduates to be passionate about reaching goals – Baltimore Sun
Kevin Plank encourages University of Maryland graduates to let "passion" fuel their dreams Kevin Plank remembers sitting in his cap and gown at the…
Read More
NIH names Johns Hopkins a Center of Excellence for bioethics research – EurekAlert! Science News
The National Human Genome Research Institute of the National Institutes of Health (NIH) has awarded the Johns Hopkins Berman Institute of Bioethics a "Center…
Read More
Roche receives FDA Approval for novel PD-L1 biomarker assay
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced approval of the VENTANA PD-L1 (SP142) Assay1 by the US Food and Drug Administration (FDA) as…
Read More